Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 4,329–4,336 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
XBiotech Inc. Natrunix Rheumatoid Arthritis Phase 2 Data Released Intravenous Immunology: Anti-TNF
Xencor Inc. XmAb5871 Systemic Lupus Erythematosus (SLE) Phase 2 Trial Discontinued Intravenous Immunology
Xenetic Biosciences Inc. Epolong Anemia in patients with chronic kidney disease (CKD) Phase 3 Trial Completed Oral Anti-Anemia
Xenetic Biosciences Inc. XBIO-101 Endometrial cancer Phase 2 Trial Discontinued Intravenous Oncology
Xenon Pharmaceuticals Inc. azetukalner (XEN1101) - (X-NOVA) Major depressive disorder (MDD) Phase 3 Ongoing oral Psychiatric
Xenon Pharmaceuticals Inc. Azetukalner (XEN1101) - (X-TOLE2) Adult Focal Epilepsy Phase 3 Data Released Oral Neurology
Xenon Pharmaceuticals Inc. XEN496 - (EPIK) Epilepsy Phase 3 Trial Discontinued Oral Neurology
Xenon Pharmaceuticals Inc. Azetukalnerm - (X-ACKT) Epilepsy indication of primary generalized tonic-clonic seizures (PGTCS) Phase 3 Ongoing Intravenous Neurology